<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1932">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03081728</url>
  </required_header>
  <id_info>
    <org_study_id>NK/3017/MD/051</org_study_id>
    <nct_id>NCT03081728</nct_id>
  </id_info>
  <brief_title>Incidence Of Hemidiaphragmatic Paralysis After Usg Guided Low Dose Interscalene Brachial Plexus Block</brief_title>
  <official_title>Incidence Of Hemidiaphragmatic Paralysis With Patient Controlled Infusion Of Low Volume Of Ropivacaine After Usg Guided Low Dose Interscalene Brachial Plexus Block</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Postgraduate Institute of Medical Education and Research</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Postgraduate Institute of Medical Education and Research</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      to put a catheter in interscalene brachial plexus USG guided and give a bolus of drug
      followed by 24 hours continous infusion of drug
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      to put a catheter in interscalene brachial plexus USG guided and give a bolus of drug
      followed by 24 hours continous infusion of drug. To see hemidiaphragmatic paralysis by
      seeing diaphragmatic excursion on M mode Usg subcostal approach, to see post operative pain,
      patient satisfaction score, complications if any
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 2017</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>No masking</masking>
  </study_design_info>
  <primary_outcome>
    <measure>incidence of hemidiaphragmatic paralysis</measure>
    <time_frame>24 hours</time_frame>
    <description>incidence of hemidiaphragmatic paralysis by M mode USG to be seen</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>postoperative pain</measure>
    <time_frame>24 hours</time_frame>
    <description>VAS score will taken</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Respiratory Insufficiency</condition>
  <arm_group>
    <arm_group_label>block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>will be given block and continuous infusion with bolus 10ml of 0.5% ropivacaine followed by infusion @ 2ml/hr of 0.2% ropivacaine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>IV analgesia only with diclofenac and paracetamol</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Interscalene Block with Ropivacaine Hcl 0.2% Inj Vil 10Ml</intervention_name>
    <description>bolus 10ml of 0.5% ropivacaine followed by infusion @ 2ml/hr of 0.2% ropivacaine</description>
    <arm_group_label>block</arm_group_label>
    <other_name>ROPIN</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>IV diclofenac and IV paracetamol</intervention_name>
    <description>iv diclofenac 75 mg TDS iv paracetamol 1gm TDS</description>
    <arm_group_label>control</arm_group_label>
    <other_name>vovran and perfalgan</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients aged 18-80 years and belonging to ASA grade I, II, III, undergoing either,
             shoulder surgery, (rotator cuff repair, acromioplasty, hemiarthroplasty, and total
             shoulder replacement) or surgery for proximal humerus fracture will be recruited for
             the study.

        Exclusion Criteria:

          -  a) Patient refusal for interscalene block b) Severe respiratory disease (FEV1/FVC
             &lt;0.7 and FEV1 &lt; 80% of predicted) c) Allergy to amide local anaesthetic drugs d)
             Chronic opioid therapy e) Patients who cannot understand how to operate PCA and VAS
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>pankaj kushal, MD</last_name>
    <phone>9888870526</phone>
    <email>pankajkushal23@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>tanvir smara, MD</last_name>
    <phone>7087008799</phone>
    <email>drtanvirsamra@yahoo.in</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>PGIMER</name>
      <address>
        <city>Chandigarh</city>
        <zip>160012</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>PANKAJ , MD</last_name>
      <phone>9888870526</phone>
      <email>pankajkushal23@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>TANVIR SAMRA, MD</last_name>
      <phone>7087008799</phone>
      <email>drtanvirsamra@yahoo.in</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <lastchanged_date>March 22, 2017</lastchanged_date>
  <firstreceived_date>March 12, 2017</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Postgraduate Institute of Medical Education and Research</investigator_affiliation>
    <investigator_full_name>Dr. Pankaj</investigator_full_name>
    <investigator_title>Junior resident, Department of Anaesthesia and Intensive Care, MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Paralysis</mesh_term>
    <mesh_term>Respiratory Insufficiency</mesh_term>
    <mesh_term>Pulmonary Valve Insufficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Ropivacaine</mesh_term>
    <mesh_term>Diclofenac</mesh_term>
    <mesh_term>Acetaminophen</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
